FR2804681B1 - Compose antidiabetique et procede pour sa production - Google Patents

Compose antidiabetique et procede pour sa production

Info

Publication number
FR2804681B1
FR2804681B1 FR0100207A FR0100207A FR2804681B1 FR 2804681 B1 FR2804681 B1 FR 2804681B1 FR 0100207 A FR0100207 A FR 0100207A FR 0100207 A FR0100207 A FR 0100207A FR 2804681 B1 FR2804681 B1 FR 2804681B1
Authority
FR
France
Prior art keywords
production
antidiabetic compound
antidiabetic
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0100207A
Other languages
English (en)
Other versions
FR2804681A1 (fr
Inventor
Tsuyoshi Tomiyama
Akira Tomiyama
Hiroshi Tomiyama
Keiko Kuroiwa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kotobuki Seiyaku Co Ltd
Original Assignee
Kotobuki Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kotobuki Seiyaku Co Ltd filed Critical Kotobuki Seiyaku Co Ltd
Publication of FR2804681A1 publication Critical patent/FR2804681A1/fr
Application granted granted Critical
Publication of FR2804681B1 publication Critical patent/FR2804681B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
FR0100207A 2000-01-11 2001-01-09 Compose antidiabetique et procede pour sa production Expired - Fee Related FR2804681B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000006106 2000-01-11
JP2000356303A JP4316787B2 (ja) 2000-01-11 2000-11-22 エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、

Publications (2)

Publication Number Publication Date
FR2804681A1 FR2804681A1 (fr) 2001-08-10
FR2804681B1 true FR2804681B1 (fr) 2004-06-25

Family

ID=26583525

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0100207A Expired - Fee Related FR2804681B1 (fr) 2000-01-11 2001-01-09 Compose antidiabetique et procede pour sa production

Country Status (9)

Country Link
US (1) US6414001B2 (fr)
JP (1) JP4316787B2 (fr)
KR (1) KR20010070442A (fr)
CN (1) CN1227231C (fr)
DE (1) DE10100772B4 (fr)
ES (1) ES2187261B2 (fr)
FR (1) FR2804681B1 (fr)
GB (1) GB2359082B (fr)
IT (1) ITMI20010042A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030027054A (ko) 2000-08-23 2003-04-03 일라이 릴리 앤드 캄파니 옥사졸릴-아릴프로피온산 유도체 및 ｐｐａｒ효능제로서의 그의 용도
ES2295200T3 (es) 2000-08-23 2008-04-16 Eli Lilly And Company Derivados de acido oxazolil-arilpropionico y su uso como agonistas de ppar.
ES2288982T3 (es) * 2000-08-23 2008-02-01 Eli Lilly And Company Derivados de acido oxazolil-ariloxiacetico y su uso como agonistas ppar.
US7009057B2 (en) * 2001-04-26 2006-03-07 Zentiva A.S. Method for obtaining pioglitazone as an antidiabetic agent
ES2275887T3 (es) 2001-06-07 2007-06-16 Eli Lilly And Company Moduladores de receptores activados por proliferadores de peroxisoma (ppar).
US20030171377A1 (en) * 2001-08-29 2003-09-11 Bigge Christopher Franklin Antidiabetic agents
TWI281916B (en) 2001-10-25 2007-06-01 Lilly Co Eli Antitumor compounds and methods
US6716842B2 (en) 2002-04-05 2004-04-06 Warner-Lambert Company, Llc Antidiabetic agents
US7144911B2 (en) * 2002-12-31 2006-12-05 Deciphera Pharmaceuticals Llc Anti-inflammatory medicaments
US7279576B2 (en) * 2002-12-31 2007-10-09 Deciphera Pharmaceuticals, Llc Anti-cancer medicaments
US7202257B2 (en) * 2003-12-24 2007-04-10 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
US20080045706A1 (en) * 2002-12-31 2008-02-21 Flynn Daniel L Anti-inflammatory medicaments
EP1597248B1 (fr) 2003-02-14 2007-12-26 Eli Lilly And Company Dérivés de sulfonamides utilisés comme modulateurs du récepteur ppar
US7348453B2 (en) * 2003-09-04 2008-03-25 Mirus Bio Corporation Labile linkage for compound delivery to a cell
JP4175291B2 (ja) * 2004-05-12 2008-11-05 トヨタ自動車株式会社 車両の減速制御装置
DE102004039509B4 (de) * 2004-08-14 2006-09-21 Sanofi-Aventis Deutschland Gmbh Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE602004014277D1 (de) * 2004-10-22 2008-07-17 Bioprojet Soc Civ Neue Dicarbonsäurederivate
CN101735048A (zh) * 2008-11-05 2010-06-16 上海慈瑞医药科技有限公司 具胰岛素增敏活性的水杨酸类化合物及其制备方法
IN2014MN02574A (fr) 2012-05-22 2015-07-24 Genentech Inc
WO2014008458A2 (fr) * 2012-07-06 2014-01-09 Genentech, Inc. Benzamides n-substitués et leurs procédés d'utilisation
KR20150074123A (ko) 2012-10-26 2015-07-01 머크 샤프 앤드 돔 코포레이션 전압-게이팅 나트륨 채널에서 선택적 활성을 갖는 n-치환된 인다졸 술폰아미드 화합물
CN112028833B (zh) * 2020-09-25 2022-07-05 西南大学 对氨基水杨酸唑类衍生物及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989008652A1 (fr) * 1988-03-08 1989-09-21 Pfizer Inc. Derives de thiazolidinedione comme agents hypoglycemiques
US5239080A (en) * 1989-02-08 1993-08-24 Takeda Chemical Industries, Ltd. Oxazole compounds and their use as antidiabetic and bone-reduction inhibitory agents
ATE116971T1 (de) * 1990-08-23 1995-01-15 Pfizer Hypoglykämische hydroxyharnstoffderivate.
TW245716B (fr) * 1992-12-28 1995-04-21 Takeda Pharm Industry Co
TW268952B (fr) * 1993-02-26 1996-01-21 Takeda Pharm Industry Co Ltd
US5641796A (en) * 1994-11-01 1997-06-24 Eli Lilly And Company Oral hypoglycemic agents
GB9604242D0 (en) * 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
CZ53699A3 (cs) * 1996-08-19 1999-07-14 Japan Tobacco Inc. Deriváty propionové kyseliny a jejich použití
DE69941777D1 (de) * 1998-03-10 2010-01-21 Ono Pharmaceutical Co Carbonsäurederivate und medikamente die diese als aktiven wirkstoff enthalten
WO2001016111A2 (fr) * 1999-08-27 2001-03-08 Eli Lilly And Company Sulfonyl pyrazolones et pyrazolines hypoglycemiques
US6617343B1 (en) * 1999-08-27 2003-09-09 Eli Lilly And Company Hypoglycemic N,N-arylsulfonylglycine compounds

Also Published As

Publication number Publication date
US6414001B2 (en) 2002-07-02
DE10100772B4 (de) 2005-09-22
ES2187261B2 (es) 2004-07-16
JP2001261662A (ja) 2001-09-26
CN1227231C (zh) 2005-11-16
CN1315320A (zh) 2001-10-03
ITMI20010042A1 (it) 2002-07-11
US20010008898A1 (en) 2001-07-19
DE10100772A1 (de) 2001-07-19
ES2187261A1 (es) 2003-05-16
GB0100433D0 (en) 2001-02-21
GB2359082B (en) 2004-09-29
GB2359082A (en) 2001-08-15
FR2804681A1 (fr) 2001-08-10
KR20010070442A (ko) 2001-07-25
JP4316787B2 (ja) 2009-08-19

Similar Documents

Publication Publication Date Title
FR2804681B1 (fr) Compose antidiabetique et procede pour sa production
DE60121878D1 (de) Mikroaktor und dessen Herstellungsverfahren
DE60205413D1 (de) Herstellungsverfahren
BR0207423B1 (pt) "aparelho e método para compactar com cascalho um intervalo de produção de um poço"
AR024800A1 (es) Proceso de produccion de fenil-alcanos
ITRM20000228A0 (it) Scidula multistrato e procedimento per la sua produzione.
FR2833838B1 (fr) Procede de fabrication d'un comprime incluant un analgesique de type morphinique et comprime obtenu
ID28489A (id) Metode untuk membuat 4-karboksiamino-2-disubstitusi 1,2,3,4-tetrahidroquinolin
DE69906787D1 (de) Neue produktionsmethode
DE60129014D1 (de) Aufzeichnungsblatt und dessen herstellungsverfahren
FR2852947B1 (fr) Materiau inorganique a structure hierarchisee, et procede pour sa preparation
IT1307819B1 (it) Metodo e dispositivo per la produzione di carta multistrato erelativo prodotto.
NO20001134L (no) FremgangsmÕte for fremstilling av VCM
FR2845399B1 (fr) Zone d'affichage et procede permettant sa fabrication.
MA25410A1 (fr) Procede meunier
DE60130426D1 (de) Aluminiumoxid-Leuchtstoff- Herstellungsverfahren
FR2814529B1 (fr) Procede d'assemblage de portails
BR0015861B1 (pt) método de produção de composição de poliamina.
FR2827285B1 (fr) Reactif et procede pour la perfluoroalcoylation
FR2809657B1 (fr) Procede de fabrication d'element de mobilier
FR2802897B3 (fr) Paquet de cigarettes, flan et procede pour sa fabrication
DE60008319D1 (de) IL-12 Produktionsinhibitor
AU7400401A (en) Method for the production of 2- coumarone and substituted 2-coumarones
NO993463L (no) Stålproduksjonsmetode
FR2802460B1 (fr) Procede de fabrication d'un produit en bois lamelle-colle et produit ainsi obtenu

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20100930